In NSCLC, common mutations of this pathway include serine/threonine kinase 11 (STK11 aka LKB1) which is inactivated in 17% of cases, PTEN (3%), PIK3CA (4%), and AKT1 (1%) (50). The gene discussed is STK11; the disease is non-small cell lung carcinoma.